Eli Lilly: The One-Way Ride Can't Last Forever (Rating Downgrade)

AI BRIEFING

• ⬤ Eli Lilly downgraded to Hold due to cooling growth
• ⬤ Valuation remains rich despite downgrade
• ⬤ Novo Nordisk price pressure increases